CALL US
CALL ME BACK
888-605-5888

Transplant

Kidney Transplant Outcomes

Explore the Transplant Journey   Living Donor Program   Access FAQs
 

The Piedmont Transplant Institute is among the top 15 percent in overall transplant volumes nationally. The Transplant team continues to have excellent outcomes with graft and patient survival rates exceeding national expectations.  

The correlation between our expertise and outcomes is clear. Piedmont Transplant Institute's statistics compare favorably with those of several other transplant programs in the nation.

 

Piedmont has the lowest mortality rates in the region – more of our patients survive after transplant.

 

Piedmont has the lowest long-term graft loss in the region – our transplanted kidneys function successfully, longer.

 


Kidney Transplant Outcomes Data

 

MEDIAN TIMES FROM
WAIT-LIST TO KIDNEY TRANSPLANT:*
 
*Source: www.srtr.org. 7/2008 – 12/2013.

 

1-YEAR KIDNEY TRANSPLANTS PATIENT SURVIVAL*
KIDNEY TRANSPLANTS by TYPE
Piedmont
Expected
National
LIVING DONOR
99.28
98.96
98.91
DECEASED DONOR
97.51
96.73
96.58
ALL DONOR TYPES
98.28
97.69
97.36
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2014 – 12/2016.

 

3-YEAR KIDNEY TRANSPLANTS PATIENT SURVIVAL*
KIDNEY TRANSPLANTS by TYPE
Piedmont
Expected
National
LIVING DONOR
95.68
95.66
96.25
DECEASED DONOR
97.51
96.73
96.58
ALL DONOR TYPES
98.28
97.69
97.36
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2011 – 12/2013.

 

1-YEAR KIDNEY TRANSPLANTS GRAFT SURVIVAL*
KIDNEY TRANSPLANTS by TYPE
Piedmont
Expected
National
LIVING DONOR
98.03
97.88
97.81
DECEASED DONOR
91.58
94.06
94.01
ALL DONOR TYPES
94.34
95.68
95.23
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2014 – 12/2016.
 

 

3-YEAR KIDNEY TRANSPLANTS GRAFT SURVIVAL*
KIDNEY TRANSPLANTS by TYPE
Piedmont
Expected
National
LIVING DONOR
94.80
92.36
92.93
DECEASED DONOR
89.71
85.16
86.10
ALL DONOR TYPES
92.24
88.74
88.49
*Source: www.srtr.org. For patients receiving their first transplant of this type between 7/2011 – 12/2013.
 

 

KIDNEY TRANSPLANT DATA*
KIDNEY TRANSPLANTS by TYPE
Piedmont
Region 
Nation
DECEASED DONOR
82
 1,869 13,841
LIVING DONOR
57
 608 5,722
TOTAL
139
 2,477 19,563
% LIVING DONOR
41.0
 24.5 29.2
*Source: www.srtr.org. Center activity 7/2016 – 6/2017.

 

 
1-YEAR KIDNEY TRANSPLANT PATIENT SURVIVAL*
PATIENT SURVIVAL
Actual
Expected
Piedmont
98.28
97.69
Emory
95.95
97.49
AUMC
95.06
97.14
Mayo Clinic (JAX)
95.52
97.18
Shands (UNIV FLA).
98.65
97.89
Florida Hospital
95.61
97.01
MUSC
98.06
97.26
UAB 96.78 97.33
National
97.36
N/A
*Source: www.srtr.org. 7/2014 – 12/2016.
 
3-YEAR KIDNEY TRANSPLANT PATIENT SURVIVAL*
PATIENT SURVIVAL
Actual
Expected
Piedmont
94.57
93.71
Emory
93.12
93.63
AUMC
89.51
92.92
Mayo Clinic (JAX)
95.10
93.67
Shands (UNIV FLA)
90.62
94.33
Florida Hospital
94.17
94.32
UAB
92.04
93.15
MUSC
93.09
93.35
National
93.61
N/A
*Source: www.srtr.org. 7/2011 – 12/2013.
 
1-YEAR KIDNEY TRANSPLANT GRAFT SURVIVAL*
PATIENT SURVIVAL
Actual
Expected
Piedmont
94.34
95.68
Emory
94.55
95.21
AUMC
93.30
94.76
Mayo Clinic (JAX)
92.50
94.72
Shands (UNIV FLA)
93.55
95.81
Florida Hospital
94.11
94.83
MUSC 94.70 94.93
UAB
94.92
95.06
National
95.23
N/A
*Source: www.srtr.org. 7/2014 – 12/2016.
 
3-YEAR KIDNEY TRANSPLANT GRAFT SURVIVAL*
PATIENT SURVIVAL
Actual
Expected
Piedmont
92.24
88.74
Emory
89.26
87.54
AUMC
82.58
86.98
Mayo Clinic (JAX)
89.08
88.68
Shands (UNIV FLA)
86.32
88.59
Florida Hospital
88.94
88.45
UAB
88.91
87.21
MUSC
85.68
86.85
National
88.49
N/A
*Source: www.srtr.org. 7/2011 – 12/2013.
 
 
WAITING LIST MORTALITY*
PATIENT SURVIVAL
ACTUAL
EXPECTED
RATE RATIO ESTIMATE
Piedmont 164* 7.6 13.4 0.58
Emory 199 20.2 18.0 1.12
Mayo Clinic (JAX) 98 11.0 19.9 0.57
Shands (UNIV FLA) 116
13.9
 15.1 0.92
Florida Hospital 49
15.2
 14.0 1.07
MUSC 48
27.6
 27.6 1.00
UAB 128
17.4
 17.8 .98
*Count on waiting list at start.
*Source: www.srtr.org. Center activity 7/2015 – 6/2017.

For additional information on outcomes, visit the SRTR website.